Harborside


Greenrise Global Brands Inc.

CNSX: XCX


Canadian symbol: XCX.CN
US symbol:

Currency in CAD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -0.06
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.4800
52 Week Low 30.1650
50-Day Moving Average 30.2040
200-Day Moving Average 30.2992

Share Statistics

Avg Vol (3 month) 313.44k
Avg Vol (10 day) 38.51k
Shares Outstanding 536.86M
Implied Shares Outstanding 6N/A
Float 828.07M
% Held by Insiders 118.34%
% Held by Institutions 10.00%
Shares Short (Apr 13, 2022) 425
Short Ratio (Apr 13, 2022) 40
Short % of Float (Apr 13, 2022) 4N/A
Short % of Shares Outstanding (Apr 13, 2022) 40.00%
Shares Short (prior month Jan 30, 2022) 421.26k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4May 02, 2012
Last Split Factor 23:1
Last Split Date 3Dec 12, 2018

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sept 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-507.60%

Management Effectiveness

Return on Assets (ttm)-371.64%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)416.22k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)177.70%
Gross Profit (ttm)-153
EBITDA N/A
Net Income Avi to Common (ttm)-2.22M
Diluted EPS (ttm)-0.1090
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.99k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.65M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.78
Book Value Per Share (mrq)-0.05

Cash Flow Statement

Operating Cash Flow (ttm)-1.89M
Levered Free Cash Flow (ttm)-1.16M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
XCX.CN
Greenrise Global Brands
6 months ago
XCX.CN
Greenrise Global Brands
7 months ago
XCX.CN
Greenrise Global Brands
7 months ago
XCX.CN
Greenrise Global Brands
8 months ago
XCX.CN
Greenrise Global Brands
1 year ago
XCX.CN
Greenrise Global Brands
2 years ago
XCX.CN
Greenrise Global Brands
2 years ago
XCX.CN
Greenrise Global Brands
2 years ago
XCX.CN
Greenrise Global Brands
2 years ago
XCX.CN
Greenrise Global Brands
2 years ago

Currency in CAD
Earnings EstimateCurrent Qtr.Next Qtr.Current YearNext Year
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPSN/AN/AN/AN/A
Revenue EstimateCurrent Qtr.Next Qtr.Current YearNext Year
No. of Analysts0000
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings HistoryInvalid DateInvalid DateInvalid DateInvalid Date
EPS Est.N/AN/AN/AN/A
EPS ActualN/AN/AN/AN/A
DifferenceN/AN/AN/AN/A
Surprise %N/AN/AN/AN/A
EPS TrendCurrent Qtr.Next Qtr.Current YearNext Year
Current Estimate0000
7 Days Ago0000
30 Days Ago0000
60 Days Ago0000
90 Days Ago0000
EPS RevisionsCurrent Qtr.Next Qtr.Current YearNext Year
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesXCX.CNIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current YearN/AN/AN/AN/A
Next YearN/AN/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)-40.85%N/AN/AN/A


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
18.34%% of Shares Held by All Insider
0.00%% of Shares Held by Institutions
0.00%% of Float Held by Institutions
0Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Greenrise Global Brands Inc.


Greenrise Provides Update on CannaCare's Sales Growth and First Quarter Results

Greenrise Provides Update on CannaCare’s Sales Growth and First Quarter Results

HAMBURG, GERMANY, June 20, 2022 - Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise"), which operates in the German CBD wellbeing and medical cannabis market announces its results for the three months ending March 31st, 2022 (Q1, 2022) and provides an update about the acquisition of CannaCare Health... Read More...
Greenrise Announces Appointment of Frank Otto to the Board of Directors and Closing of the Acquisition of Control of CannaCare Health GmbH

Greenrise Announces Appointment of Frank Otto to the Board of Directors and Closing of the Acquisition of Control of CannaCare Health GmbH

HAMBURG, Germany, May 11, 2022 - Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise''), which serves the medical and CBD cannabis market in Germany and CannaCare Health GmbH ("CannaCare"), owner of CANOBO, one of Germany's leading CBD brands announces the appointment of Mr. Frank Otto to the board of... Read More...
Greenrise Advances its Leadership Position in Germany with the Acquisition of a Majority Interest in CannaCare Health GmbH and the Appointment of Frank Otto to its Board of Directors

Greenrise Advances its Leadership Position in Germany with the Acquisition of a Majority Interest in CannaCare Health GmbH and the Appointment of Frank Otto to its Board of Directors

This major acquisition immediately strengthens Greenrise's position in the CBD wellness market and builds on Greenrise's strategy to become a leader in the adult-use cannabis market in Germany. Successful German business leaders Frank Otto and Michael Oplesch have strong backgrounds in the TV, health, and cosmetic industries and have bu... Read More...
Greenrise Global's Medical Cannabis Subsidiary, AMP Alternative Medical Products GmbH becomes Exclusive Distribution Partner of a Selection of Little Green Pharma Extracts in Germany

Greenrise Global’s Medical Cannabis Subsidiary, AMP Alternative Medical Products GmbH becomes Exclusive Distribution Partner of a Selection of Little Green Pharma Extracts in Germany

AMP has entered into a three-year exclusive pharmaceutical distribution agreement for LGP Classic full-plant cannabis extract oils. LGP medical cannabis products have been registered for sale with the relevant authorities in Germany and include 20:5 LGP Classic and 10:10 LGP Classic extract oils in 30 and 50 milliliter sizes. Doctors and... Read More...
Greenrise Global's Medical Cannabis Subsidiary, AMP Alternative Medical Products GmbH Announces the Beginning of Dronabinol Sales in Germany

Greenrise Global’s Medical Cannabis Subsidiary, AMP Alternative Medical Products GmbH Announces the Beginning of Dronabinol Sales in Germany

Dronabinol is pure Tetrahydrocannabinol (THC) and is registered as an active pharmaceutical ingredient (API) and has been registered for sale with the appropriate authorities in Germany. Doctors and pharmacists can find more information about the product or order on AMP's website: https://amp-eu.com/doccheck-login/ AMP and Eurox entered... Read More...
Year-end Letter to the Shareholders

Year-end Letter to the Shareholders

BERLIN,, Dec. 22, 2021 - Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise Global") is pleased to provide a year-end letter to its shareholders. Dear Fellow Shareholders, Germany's time has come. The formation of the German government this month confirmed that recreational cannabis for adult use w... Read More...
Greenrise Global's Supports Germany's Approach to Cannabis Legalization for Adult Use

Greenrise Global’s Supports Germany’s Approach to Cannabis Legalization for Adult Use

BERLIN and ERFURT, Germany, Nov. 25, 2021 - Greenrise Global Brands Inc. (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise Global") would like to comment on the German coalition government's (SPD, Alliance 90/The Greens and FDP) announcement to legalize the sale of cannabis for c... Read More...
Greenrise Global's Medical Cannabis Subsidiary Announces the Introduction of its Dronabinol Product to the German Market

Greenrise Global’s Medical Cannabis Subsidiary Announces the Introduction of its Dronabinol Product to the German Market

BERLIN and ERFURT, Germany, Nov. 17, 2021 - Greenrise Global Brands Inc.'s (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX), wholly-owned subsidiary, AMP Alternative Medical Products GmbH ("AMP"), a pharmaceutical supplier of medical cannabis products to German pharmacies, announces the lau... Read More...
AMP Announces Strategic Acquisition of German CBD Wellness Company and Leading Cannabis Executive Team

AMP Announces Strategic Acquisition of German CBD Wellness Company and Leading Cannabis Executive Team

BERLIN, Nov. 3, 2021 - AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX), (the "Company") announces it has acquired Greenrise GmbH ("Greenrise Wellbeing") from its founders, Messrs. Hendrik Knopp, Florian Witt and Alex Hintz. Mr. Hendrik Knopp has been appointed to the board of directors, Mr. Florian ... Read More...
AMP Becomes Exclusive Marketing Partner of Tilray for Aphria Medical Cannabis Brand in Germany

AMP Becomes Exclusive Marketing Partner of Tilray for Aphria Medical Cannabis Brand in Germany

The new cooperation of AMP with Tilray as their sole marketing partner in Germany for the Aphria brand is based on a supply and marketing agreement with CC Pharma GmbH, a wholly-owned subsidiary of Tilray. The conclusion of this agreement is a milestone for AMP in providing a complete catalogue of medical cannabis products for doctors to... Read More...
AMP Alternative Medical Products and Waldhausklinik Deuringen Announce Clinical Study into the Effects of Medical Cannabis

AMP Alternative Medical Products and Waldhausklinik Deuringen Announce Clinical Study into the Effects of Medical Cannabis

ERFURT, Germany and BERLIN and STADTBERGEN, Germany, Sept. 13, 2021 - AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis products to German pharmacies, and WaldhausKlinik Deuringen gGmbH ("Waldhausklinik"), a  non-profit acute care hospital for internal me... Read More...
AMP Launches its CBD Brand, CANAVEX¬ģ at YES!CON, Germany's Largest Cancer Convention

AMP Launches its CBD Brand, CANAVEX¬ģ at YES!CON, Germany’s Largest Cancer Convention

AMP created CANAVEX¬ģ¬†for cosmetic use and sold exclusively by pharmacists without a doctor's prescription.¬† CANAVEX¬ģ¬†formulation includes high quality CBD, which is sourced from Germany and EU-GMP compliant, organic hemp seed oil and vitamin E. CANAVEX¬ģ's initial products are Basic CBD 5, which contains 500mg or 5% CBD and Basic CBD 10, w... Read More...
AMP German Cannabis Group and Aphria's subsidiary CC Pharma GmbH enter into Strategic Co-Promotion Agreement for the Sale of Medical Cannabis in Germany

AMP German Cannabis Group and Aphria’s subsidiary CC Pharma GmbH enter into Strategic Co-Promotion Agreement for the Sale of Medical Cannabis in Germany

ERFURT/BERLIN/DENSBORN, Germany, and LEAMINGTON, ON, Canada, Jan. 26, 2021 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028) and Aphria Inc.'s ("Aphria") (TSX: APHA) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH ("CC Pharma"), have entered into a strategic agreement (the "Co-Promoti... Read More...
AMP German Cannabis Group Provides Year-end Letter to Shareholders

AMP German Cannabis Group Provides Year-end Letter to Shareholders

ERFURT, Germany and BERLIN, Dec. 16, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (Frankfurt: C4T) (ISIN: CA00176G1028) is pleased to provide a letter to its shareholders. Dear Shareholders, The upcoming year will be transformational for AMP and the medical cannabis industry in Germany and globally. AMP's focus has always b... Read More...
AMP Presents Round Table Discussion on Medical Cannabis in the Focus of German Politics with Dr. Wieland Schinnenburg, MdB (FDP)

AMP Presents Round Table Discussion on Medical Cannabis in the Focus of German Politics with Dr. Wieland Schinnenburg, MdB (FDP)

ERFURT, Germany and BERLIN, Nov. 30, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) is proud to present the second episode of its "Round Table" series with Dr. Wieland Schinnenburg, MdB of the FDP, who provides an up-to-date overview of the political issues and challenges facing the medical cannab... Read More...
AMP German Cannabis Group enters into long term supply agreement with Danish medical cannabis producer Schroll Medical

AMP German Cannabis Group enters into long term supply agreement with Danish medical cannabis producer Schroll Medical

ERFURT, Germany and BERLIN and ÅRSLEV, Denmark, Nov. 5, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028), providing German patients with a wide range of pharmaceutical grade medical cannabis products and Schroll Medical ApS ("Schroll"), a Danish cultivator of medical cannabis, announce that t... Read More...
AMP German Cannabis Group adds Little Green Pharma medical cannabis extracts from Australia to its sales offering

AMP German Cannabis Group adds Little Green Pharma medical cannabis extracts from Australia to its sales offering

AMP is looking forward to offering premium EU-GMP full plant extract cannabis oil medicines branded under the LGP Classic brand, produced by the same consistent strains.  AMP wants to introduce the LGP brand to the German market by selling "LGP Classic 20:5 Oils" (THC dominant) and additional products in the near term once AMP has establ... Read More...
AMP German Cannabis Group Hires Experienced Sales Director from Canopy Growth

AMP German Cannabis Group Hires Experienced Sales Director from Canopy Growth

ERFURT and BERLIN, Germany, Sept. 15, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028), a licenced importer of medical cannabis into Germany, is pleased to announce the appointment of Mr. Marc Wälken as Sales Director, effective immediately. Mr. Wälken joins AMP from Spectrum Therapeutics, a brand o... Read More...
AMP German Cannabis Group enters into Supply Agreement with Canadian Medical cannabis producer, Eve & Co

AMP German Cannabis Group enters into Supply Agreement with Canadian Medical cannabis producer, Eve & Co

ERFURT and BERLIN, Germany and TORONTO, Aug. 11, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) and Eve & Co. Incorporated ("Eve & Co.") (TSXV: EVE) (QTCQX: EEVVF) announce they have entered into a supply agreement for the purchase and export to Germany of European Union Good Manufacturing... Read More...
AMP German Cannabis Group Presents Roundtable Discussion with European Medical Cannabis Expert, Dr. Franjo Grotenhermen and Dr. Stefan Feuerstein about Medical Cannabis in Germany

AMP German Cannabis Group Presents Roundtable Discussion with European Medical Cannabis Expert, Dr. Franjo Grotenhermen and Dr. Stefan Feuerstein about Medical Cannabis in Germany

ERFURT and BERLIN, Germany, Aug. 4, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) proudly presents its first video in a series of in-depth roundtable discussions that will explore and discuss new developments regarding medical cannabis in Germany. The Roundtable Series online videos are in German... Read More...
AMP German Cannabis Group orders 150 kilograms of medical cannabis from Canadian Licensed Producer

AMP German Cannabis Group orders 150 kilograms of medical cannabis from Canadian Licensed Producer

ERFURT and BERLIN, Germany, July 21, 2020 - AMP German Cannabis Group Inc. ("AMP") (FSE: C4T) (ISIN: CA00176G1028) (CSE: XCX) announces it has placed two orders for bulk and finished EU-GMP medical cannabis flower from a Canadian Licensed Producer ("Canadian LP") of medical cannabis. AMP will be purchasing and importing to Germany, 50 kil... Read More...
AMP German Cannabis Group to begin medical cannabis imports from the Netherlands

AMP German Cannabis Group to begin medical cannabis imports from the Netherlands

ERFURT and BERLIN, Germany, July 6, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) announces further to its June 5, 2020 news release The Office of Medical Cannabis ("OMC"), the government organization of the Netherlands for distribution of medical cannabis products, has notified AMP that it will r... Read More...
AMP German Cannabis Group announces AGM results and appointment of new CFO

AMP German Cannabis Group announces AGM results and appointment of new CFO

ERFURT and BERLIN, Germany , June 29, 2020 - AMP German Cannabis Group Inc. ("AMP") (C4T.F) (ISIN:CA00176G1028) (XCX.CN) held its annual general meeting of shareholders (AGM) earlier today. The shareholders approved all resolutions put before them, namely:Re-electing Dr. Stefan Feuerstein and Messrs. Alex Blodgett , Claudio Morandi and Ke... Read More...
AMP German Cannabis Group to develop medical cannabis brands for the German market

AMP German Cannabis Group to develop medical cannabis brands for the German market

AMP is fully licenced to import medical cannabis from Europe and other countries Building brands for the German medical cannabis market supplied by foreign licenced producers Large volume Canadian imports projected to begin in the fall of 2020 under AMP brand ERFURT, Germany and BERLIN, June 8, 2020 - AMP German Cannabis Group Inc. ("... Read More...
AMP German Cannabis Group sets date for Annual General Meeting and Online Question & Answer Session

AMP German Cannabis Group sets date for Annual General Meeting and Online Question & Answer Session

ERFURT, Germany and BERLIN , June 2, 2020 - AMP German Cannabis Group Inc. ("AMP") (XCX.CN) (FSE: C4T, ISIN: CA00176G1028) will hold its Annual General Meeting of Shareholders (AGM) on Monday, June 29 th, 2020, beginning at 3:00 p.m. Central European Time (6:00 a.m. Pacific Standard Time) to conduct formal business follow by an online que... Read More...
AMP German Cannabis Group Receives Irradiation Licence for Medical Cannabis Imports into Germany

AMP German Cannabis Group Receives Irradiation Licence for Medical Cannabis Imports into Germany

BERLIN, April 14, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) is pleased to announce it has successfully obtained all the required licences to import, store at its licensed narcotic storage facility and distribute to its pharmaceutical distributors irradiated EU-GMP certified medical cannabis fl... Read More...
AMP German Cannabis Group Receives Import Licence for Medical Cannabis for Imports from European Union Countries

AMP German Cannabis Group Receives Import Licence for Medical Cannabis for Imports from European Union Countries

BERLIN, March 9, 2020 - AMP German Cannabis Group Inc. ("AMP")¬†(CSE: XCX) (FSE: C4T, ISIN:¬†CA00176G1028) announces that the Thuringian State Office for Consumer Protection or Th√ľringer Landesamt f√ľr Verbraucherschutz, ("TLV")¬†has granted an additional import licence for cannabis products for medical purposes from European countries to Ger... Read More...
AMP German Cannabis Group Receives an Import Licence for Medical Cannabis from the German State of Thuringia

AMP German Cannabis Group Receives an Import Licence for Medical Cannabis from the German State of Thuringia

BERLIN and ERFURT, Germany, Nov. 18, 2019 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces the Thuringian State Office for Consumer Protection (Thueringer Landesamt fuer Verbraucherschutz) ("TLV") has granted an import licence for cannabis products for medical purposes for Germany accordi... Read More...
AMP German Cannabis Group Signs Distribution Agreement with CC Pharma, a Wholly Owned Subsidiary of Aphria and a Leading Pharmaceutical and Medical Cannabis Distributer in Germany

AMP German Cannabis Group Signs Distribution Agreement with CC Pharma, a Wholly Owned Subsidiary of Aphria and a Leading Pharmaceutical and Medical Cannabis Distributer in Germany

AMP to supply the growing Germany market with pharmaceutical medical cannabis imported from Canada ERFURT, Germany and BERLIN, Oct. 15, 2019 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) through its wholly-owned subsidiary AMP Alternative Medical Products GmbH ("AMP Germany") has entered into a ... Read More...
AMP German Cannabis Group begins EU-GMP audit of its medical cannabis supply chain in Germany

AMP German Cannabis Group begins EU-GMP audit of its medical cannabis supply chain in Germany

BERLIN, Oct. 10, 2019 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces that it has begun conducting an European Union (EU) Good Manufacturing Procedure (EU-GMP) audit of its supply chain logistics in Germany to ensure that the quality and integrity of pharmaceutical goods during transport... Read More...
AMP German Cannabis Group Enters into memorandum of understanding supply agreement for the import of EU-GMP medical cannabis into Germany

AMP German Cannabis Group Enters into memorandum of understanding supply agreement for the import of EU-GMP medical cannabis into Germany

BERLIN, Oct. 8, 2019 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces that it has entered into a non-binding memorandum of understanding to purchase up to 1,200 kilograms of either branded or white-labeled European Union - Good Manufacturing Practice (EU-GMP) medical cannabis flower annua... Read More...
Coming Soon.
IndexLast% Change
S&P 5003,911.74

3.06%Positive

Euro STOXX 503,533.17

2.82%Positive

FTSE 1007,208.81

2.68%Positive

Nikkei 22526,491.97

1.23%Positive


Delayed data (1h)
IndexLast% Change
S&P 5003,911.74

3.06%Positive

Euro STOXX 503,533.17

2.82%Positive

FTSE 1007,208.81

2.68%Positive

Nikkei 22526,491.97

1.23%Positive



Share this page